Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 4/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | GCK | P35557 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | DHFR | P00374 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19715648 | 0.79 | GRM5 (0.36) | GRM5KDM4CNPC1RAB9AGCK | |
| SCHEMBL29067795 | 0.76 | KDM4C (0.40) | GRM5KDM4CNPC1RAB9AGCK | |
| SCHEMBL25281590 | 0.76 | KDM4C (0.38) | GRM5KDM4CNPC1RAB9AGCK | |
| SCHEMBL29180488 | 0.75 | GRM5 (0.35) | GRM5KDM4CNPC1RAB9AGCK | |
| SCHEMBL30740316 | 0.75 | GRM5 (0.35) | GRM5KDM4CNPC1RAB9AGCK | |
| SCHEMBL30896098 | 0.74 | KDM4C (0.38) | GRM5KDM4CNPC1RAB9AGCK | |
| SCHEMBL25279093 | 0.74 | GRM5 (0.36) | GRM5KDM4CNPC1RAB9AGCK | |
| SCHEMBL21058120 | 0.74 | GRM5 (0.42) | GRM5KDM4CNPC1RAB9AGCK | |
| SCHEMBL22576701 | 0.73 | KDM4C (0.41) | GRM5KDM4CNPC1RAB9AGCK | |
| SCHEMBL29068007 | 0.73 | GRM5 (0.35) | GRM5KDM4CNPC1RAB9AGCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612153-A1 | PREPARATION OF PYRAZOLOPYRIDINE AND TRIAZOLOPYRIDINE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS | Merck Sharp & Dohme LLC (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097576-A1 | PREPARATION OF PYRAZOLOPYRIDINE AND TRIAZOLOPYRIDINE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS | MERCK SHARP & DOHME LLC (US) | 2024-05-10 | — | — | WO | disclosed |